RBC Europe’s AstraZeneca AZN Stock Holding History

RBC Europe’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$73K	Hold	550	–	–	﹤0.01%	289
2022 Q1	$73K	Hold	550	–	–	﹤0.01%	316
2021 Q4	$64K	Buy	550 +100	+22%	+$11.8K	﹤0.01%	331
2021 Q3	$54.1K	Hold	450	–	–	﹤0.01%	555
2021 Q2	$53.9K	Hold	450	–	–	﹤0.01%	576
2021 Q1	$44.7K	Sell	450 -350	-44%	-$35.2K	﹤0.01%	576
2020 Q4	$80K	Hold	800	–	–	﹤0.01%	426
2020 Q3	$87.7K	Buy	+800	New	+$89K	0.01%	371
2018 Q1	–	Sell	-300	Closed	-$20.8K	–	1128
2017 Q4	$20.8K	Hold	300	–	–	﹤0.01%	670
2017 Q3	$20.3K	Buy	+300	New	+$19K	﹤0.01%	680

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RBC Europe's AZN Position: Q2 2022 in Review

RBC Europe held its AstraZeneca (AZN) position steady in Q2 2022 at 550 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #289.

RBC Europe first reported a position in AZN in Q3 2017 and has held it in 10 quarters since. The position peaked at $87.7K in Q3 2020. 1,016 funds tracked by Wall St. Rank hold AZN as of Q2 2022.

RBC Europe held 550 shares of AstraZeneca worth $73K as of Q2 2022.
RBC Europe left its AstraZeneca share count unchanged in Q2 2022.
AstraZeneca made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #289 holding.
RBC Europe first reported a position in AstraZeneca in Q3 2017 and has held it in 10 quarters since.
RBC Europe's AstraZeneca position peaked at $87.7K in Q3 2020.
1,016 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.